把供应商、客户、政府合同、重大协议、项目与产能做成逐条可核验的关系账本。 每条边都保留方向、证据等级、原文、日期和官方链接，不把“属于同一产业链”当成真实供销关系。
| 关系方向 | 关系 / 状态 | 金额 / 产能 | 证据 | 披露日期 | 详情 |
|---|---|---|---|---|---|
Adaptive Biotechnologies CorporationADPT National Institutes of Health ADAPTIVE BIOTECHNOLOGIES CORPORATION:1186779 [24-013767] | 政府合同 已完成 置信度 98% | $234.9K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $234,900 from National Institutes of Health. ADAPTIVE BIOTECHNOLOGIES CORPORATION:1186779 [24-013767] |
结构化政府合同或两端官方记录；金额与合同编号可回到原始记录核验。
SEC、公司 IR 或 EIA 正式材料点名对手方、项目或设施；方向不明确时单独标注。
海关、提单等物流信号只能作为线索，不单独写成已确认供销事实。
| 2026-07-30 |
| 核验证据 |
Adaptive Biotechnologies CorporationADPT Department of Veterans Affairs CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS | 政府合同 已完成 置信度 98% | $95.0K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $95,000 from Department of Veterans Affairs. CLONOSEQ TESTING FOR BOSTON AND WEST HAVEN VA HCS USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $29.7K — | A · 官方确认 CATALYST PHARMACEUTICALS, INC received a federal award currently valued at $29,692 from Department of Veterans Affairs. AMIFAMPRIDINE 10MG TAB USAspending.gov | 2026-07-30 | 核验证据 |
Eli Lilly and CompanyLLY Department of the Army PURCHASE OF A TOTAL OF 614,000 DOSES OF COMBINATION MONOCLONAL ANTIBODY. | 政府合同 已完成 置信度 98% | $1.29B — | A · 官方确认 ELI LILLY AND COMPANY received a federal award currently valued at $1,289,400,000 from Department of the Army. PURCHASE OF A TOTAL OF 614,000 DOSES OF COMBINATION MONOCLONAL ANTIBODY. USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $88.4K — | A · 官方确认 IMMUNOCORE COMMERCIAL LLC received a federal award currently valued at $88,358 from Department of Veterans Affairs. KIMMTRAK TABETAFUSP USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $1.11B — | A · 官方确认 ASTRAZENECA PHARMACEUTICALS LP received a federal award currently valued at $1,107,934,203 from Department of the Army. SARS-COV-2 THERAPEUTIC AZD7442 USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $86.7K — | A · 官方确认 IMMUNOCORE COMMERCIAL LLC received a federal award currently valued at $86,687 from Department of Veterans Affairs. KIMMTRAK USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $63.6K — | A · 官方确认 APPLE INC received a federal award currently valued at $63,556 from Department of State. ICASS/PROG: IPHONE 13 PRO/PRO MAX, UNLOCKED 128 GB, 256 GB USAspending.gov | 2026-07-30 | 核验证据 |
Pfizer Inc.PFE Department of the Army AWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332 | 政府合同 已完成 置信度 98% | $12.55B — | A · 官方确认 PFIZER INC received a federal award currently valued at $12,549,999,848 from Department of the Army. AWARD OF 10M TREATMENT COURSES OF ORAL PROTEASE INHIBITOR PF-07321332 USAspending.gov | 2026-07-30 | 核验证据 |
McKesson CorporationMCK Department of Veterans Affairs EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | 政府合同 已完成 置信度 98% | $1.18B — | A · 官方确认 MCKESSON CORPORATION received a federal award currently valued at $1,175,683,451 from Department of Veterans Affairs. EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH USAspending.gov | 2026-07-30 | 核验证据 |
CVS Health CorporationCVS Office of Assistant Secretary for Preparedness and Response CVS HEALTH CLINICAL TRIAL SERVICES LLC TO PROVIDE CLINICAL DECISION SUPPORT TO ALIGN COVID-19 TESTING VACCINE BREAKTHROUGH IDENTIFY, SECURE, AND PRODUCE DATA. | 政府合同 已完成 置信度 98% | $498.2K — | A · 官方确认 CVS HEALTHSPIRE PAYOR & LIFE SCIENCES LLC received a federal award currently valued at $498,152 from Office of Assistant Secretary for Preparedness and Response. CVS HEALTH CLINICAL TRIAL SERVICES LLC TO PROVIDE CLINICAL DECISION SUPPORT TO ALIGN COVID-19 TESTING VACCINE BREAKTHROUGH IDENTIFY, SECURE, AND PRODUCE DATA. USAspending.gov | 2026-07-30 | 核验证据 |
Adaptive Biotechnologies CorporationADPT National Institutes of Health COVID 19 FUNDED IMMUNOSEQ SEQUENCING SERVICES FOR COVID-19 RESEARCH PROJECT | 政府合同 已完成 置信度 98% | $308.4K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $308,400 from National Institutes of Health. COVID 19 FUNDED IMMUNOSEQ SEQUENCING SERVICES FOR COVID-19 RESEARCH PROJECT USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $29.9K — | A · 官方确认 CATALYST PHARMACEUTICALS, INC received a federal award currently valued at $29,917 from Department of Veterans Affairs. FIRDAPSE USAspending.gov | 2026-07-30 | 核验证据 |
Apple Inc.AAPL Bureau of Indian Affairs and Bureau of Indian Education APPLE - IPADS FOR THE BIE-FT. WINGATE ELEMENTARY SCHOOL | 政府合同 已完成 置信度 98% | $64.3K — | A · 官方确认 APPLE INC received a federal award currently valued at $64,320 from Bureau of Indian Affairs and Bureau of Indian Education. APPLE - IPADS FOR THE BIE-FT. WINGATE ELEMENTARY SCHOOL USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $191.0K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $191,017 from Department of Veterans Affairs. TYVASO USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $364.1K — | A · 官方确认 BRISTOL-MYERS SQUIBB COMPANY received a federal award currently valued at $364,139 from Department of Veterans Affairs. BREYANZI CAR T - TRANSPLANT USAspending.gov | 2026-07-30 | 核验证据 |
Amgen Inc.AMGN Office of Assistant Secretary for Preparedness and Response THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO | 政府合同 进行中 置信度 98% | $26.4M — | A · 官方确认 AMGEN INC. received a federal award currently valued at $26,408,674 from Office of Assistant Secretary for Preparedness and Response. THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $104.4M — | A · 官方确认 MICROSOFT CORPORATION received a federal award currently valued at $104,437,925 from Department of the Navy. MICROSOFT UNIFIED SUPPORT (MUS) USAspending.gov | 2026-07-30 | 核验证据 |
CVS Health CorporationCVS Department of Veterans Affairs GIFT CARDS RESEARCH & DEVELOPMENT PATIENT INCENTIVE FOR PARTICIPATING | 政府合同 已完成 置信度 98% | $45.1K — | A · 官方确认 CVS HEALTH CORPORATION received a federal award currently valued at $45,080 from Department of Veterans Affairs. GIFT CARDS RESEARCH & DEVELOPMENT PATIENT INCENTIVE FOR PARTICIPATING USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $69.8K — | A · 官方确认 VERICEL CORPORATION received a federal award currently valued at $69,772 from Department of Veterans Affairs. PROS KNEE CARTILAGE DEFECTS USAspending.gov | 2026-07-30 | 核验证据 |
McKesson CorporationMCK Department of Veterans Affairs EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | 政府合同 已完成 置信度 98% | $1.18B — | A · 官方确认 MCKESSON CORPORATION received a federal award currently valued at $1,184,200,532 from Department of Veterans Affairs. EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER USAspending.gov | 2026-07-30 | 核验证据 |
Eli Lilly and CompanyLLY Department of the Army PURCHASE OF 388,000 DOSES OF MONOCLONAL ANTIBODY LY-COV016. | 政府合同 已完成 置信度 98% | $329.8M — | A · 官方确认 ELI LILLY AND COMPANY received a federal award currently valued at $329,800,000 from Department of the Army. PURCHASE OF 388,000 DOSES OF MONOCLONAL ANTIBODY LY-COV016. USAspending.gov | 2026-07-30 | 核验证据 |
McKesson CorporationMCK Department of Veterans Affairs EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER | 政府合同 已完成 置信度 98% | $1.18B — | A · 官方确认 MCKESSON CORPORATION received a federal award currently valued at $1,177,854,443 from Department of Veterans Affairs. EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2025 SEPTEMBER USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $38.2K — | A · 官方确认 APPLE INC received a federal award currently valued at $38,196 from Agency for International Development. IGF::CL::IGF IPHONE 7 PLUS PROCUREMENT USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $500 — | A · 官方确认 ASTRAZENECA PHARMACEUTICALS LP received a federal award currently valued at $500 from Defense Logistics Agency. 8510242912!OTHER MEDICAL USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $636.2K — | A · 官方确认 ORACLE CORPORATION received a federal award currently valued at $636,247 from U.S. Citizenship and Immigration Services. ORACLE SOFTWARE UPGRADES AND SUPPORT USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $500 — | A · 官方确认 ASTRAZENECA PHARMACEUTICALS LP received a federal award currently valued at $500 from Defense Logistics Agency. 8508655306!OTHER MEDICAL USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $115.6K — | A · 官方确认 IMMUNOCORE COMMERCIAL LLC received a federal award currently valued at $115,583 from Department of Veterans Affairs. KIMMTRAK USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $69.8K — | A · 官方确认 VERICEL CORPORATION received a federal award currently valued at $69,772 from Department of Veterans Affairs. IMPLANT USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $69.8K — | A · 官方确认 VERICEL CORPORATION received a federal award currently valued at $69,772 from Department of Veterans Affairs. PROS IMPLANTS USAspending.gov | 2026-07-30 | 核验证据 |
Eli Lilly and CompanyLLY Department of Veterans Affairs AMYVID RADIOPHARMACEUTICAL 10 MCI FLORBETAPIR F-18 INJ,SOLN | 政府合同 进行中 置信度 98% | $229.7K — | A · 官方确认 ELI LILLY AND COMPANY received a federal award currently valued at $229,741 from Department of Veterans Affairs. AMYVID RADIOPHARMACEUTICAL 10 MCI FLORBETAPIR F-18 INJ,SOLN USAspending.gov | 2026-07-30 | 核验证据 |
Microsoft CorporationMSFT Defense Information Systems Agency MICROSOFT CONSULTING SERVICES (MCS) AND UNIFIED SUPPORT FOR THE U.S. NAVY / PROGRAM EXECUTIVE OFFICE DIGITAL AND ENTERPRISE SERVICES (PEO) DIGITAL | 政府合同 已完成 置信度 98% | $119.5M — | A · 官方确认 MICROSOFT CORPORATION received a federal award currently valued at $119,542,514 from Defense Information Systems Agency. MICROSOFT CONSULTING SERVICES (MCS) AND UNIFIED SUPPORT FOR THE U.S. NAVY / PROGRAM EXECUTIVE OFFICE DIGITAL AND ENTERPRISE SERVICES (PEO) DIGITAL USAspending.gov | 2026-07-30 | 核验证据 |
Adaptive Biotechnologies CorporationADPT Defense Health Agency CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER | 政府合同 已完成 置信度 98% | $385.9K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $385,920 from Defense Health Agency. CLONOSEQ MINIMAL RESIDUAL DISEASE IN-VITRO DIAGNOSTIC ARRAY FOR THE DEPARTMENT OF PATHOLOGY AT WALTER REED NATIONAL MILITARY MEDICAL CENTER USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $283.5K — | A · 官方确认 NOVARTIS PHARMACEUTICALS CORPORATION received a federal award currently valued at $283,527 from Department of Veterans Affairs. T CELL KYMRIAH FOR PATIENTS AT NASHVILLE VAMC USAspending.gov | 2026-07-30 | 核验证据 |
McKesson CorporationMCK Department of Veterans Affairs EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | 政府合同 已完成 置信度 98% | $1.41B — | A · 官方确认 MCKESSON CORPORATION received a federal award currently valued at $1,406,868,182 from Department of Veterans Affairs. EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER USAspending.gov | 2026-07-30 | 核验证据 |
Bristol-Myers Squibb CompanyBMY Department of Veterans Affairs REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS | 政府合同 进行中 置信度 98% | $848.4K — | A · 官方确认 BRISTOL-MYERS SQUIBB COMPANY received a federal award currently valued at $848,445 from Department of Veterans Affairs. REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS USAspending.gov | 2026-07-30 | 核验证据 |
McKesson CorporationMCK Department of Veterans Affairs EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY | 政府合同 已完成 置信度 98% | $1.40B — | A · 官方确认 MCKESSON CORPORATION received a federal award currently valued at $1,398,025,092 from Department of Veterans Affairs. EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY USAspending.gov | 2026-07-30 | 核验证据 |
AstraZeneca PLCAZN Indian Health Service ASTRA ZENECA FLUMIST 2021-2022 NON CONTRACT INFLUENZA VACCINE REQUEST FUNDS FOR NSSC CUSTOMERS | 政府合同 已完成 置信度 98% | $36.5K — | A · 官方确认 ASTRAZENECA PHARMACEUTICALS LP received a federal award currently valued at $36,525 from Indian Health Service. ASTRA ZENECA FLUMIST 2021-2022 NON CONTRACT INFLUENZA VACCINE REQUEST FUNDS FOR NSSC CUSTOMERS USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $364.1K — | A · 官方确认 BRISTOL-MYERS SQUIBB COMPANY received a federal award currently valued at $364,139 from Department of Veterans Affairs. EMERGENCY BREYANZI USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $243.8K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $243,750 from Department of Veterans Affairs. CLONO-SEQ TESTING. USAspending.gov | 2026-07-30 | 核验证据 |
Apple Inc.AAPL Agency for International Development THIS ACTION IS TO PURCHASE 15 MACBOOK AIR AND 15 MACBOOK PRO COMPUTERS AND SOME PERIPHERALS UNDER THE IT DEVICE REFRESH PROJECT WHICH WILL BE USED BY USAID STAFF IN DIFFERENT LOCATIONS. THE ESTIMATED COST IS $48,227.50 (PLEASE REFER TO THE ATTACHED QUOTE DATED MARCH 21, 20 | 政府合同 已完成 置信度 98% | $46.2K — | A · 官方确认 APPLE INC received a federal award currently valued at $46,160 from Agency for International Development. THIS ACTION IS TO PURCHASE 15 MACBOOK AIR AND 15 MACBOOK PRO COMPUTERS AND SOME PERIPHERALS UNDER THE IT DEVICE REFRESH PROJECT WHICH WILL BE USED BY USAID STAFF IN DIFFERENT LOCATIONS. THE ESTIMATED COST IS $48,227.50 (PLEASE REFER TO THE ATTACHED QUOTE DATED MARCH 21, 20 USAspending.gov | 2026-07-30 | 核验证据 |
McKesson CorporationMCK Department of Veterans Affairs EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | 政府合同 已完成 置信度 98% | $1.19B — | A · 官方确认 MCKESSON CORPORATION received a federal award currently valued at $1,191,348,081 from Department of Veterans Affairs. EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $152.8K — | A · 官方确认 VERICEL CORPORATION received a federal award currently valued at $152,800 from Department of Veterans Affairs. IMPLANT - SURGICAL USAspending.gov | 2026-07-30 | 核验证据 |
Apple Inc.AAPL Bureau of Indian Affairs and Bureau of Indian Education IPAD AIR FOR NENAHNEZAD COMMUNITY SCHOOL | 政府合同 已完成 置信度 98% | $58.1K — | A · 官方确认 APPLE INC received a federal award currently valued at $58,060 from Bureau of Indian Affairs and Bureau of Indian Education. IPAD AIR FOR NENAHNEZAD COMMUNITY SCHOOL USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $1.03B — | A · 官方确认 PFIZER INC received a federal award currently valued at $1,028,966,218 from Centers for Disease Control and Prevention. IGF::OT::IGF 2017 VACCINES FOR CHILDREN USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $154.9K — | A · 官方确认 CATALYST PHARMACEUTICALS, INC received a federal award currently valued at $154,860 from Department of Veterans Affairs. E.O.14042 AMIFAMPRIDINE (FIRDAPSE) 10MG USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $29.3K — | A · 官方确认 ASTRAZENECA PHARMACEUTICALS LP received a federal award currently valued at $29,253 from Indian Health Service. PURCHASE OF INFLUENZA VACCINE SUPPLIES FOR NSSC CUSTOMERS. USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $111.2K — | A · 官方确认 VERICEL CORPORATION received a federal award currently valued at $111,154 from Department of Veterans Affairs. MACI IMPLANT USAspending.gov | 2026-07-30 | 核验证据 |
Vericel CorporationVCEL Office of Assistant Secretary for Preparedness and Response NON SURGICAL DEBRIDEMENT | 政府合同 进行中 置信度 98% | $34.9M — | A · 官方确认 VERICEL CORPORATION received a federal award currently valued at $34,880,933 from Office of Assistant Secretary for Preparedness and Response. NON SURGICAL DEBRIDEMENT USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $4.04B — | A · 官方确认 PFIZER INC received a federal award currently valued at $4,038,717,532 from Department of the Army. COVID-19 ADULT MDV VACCINE USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $14.8K — | A · 官方确认 NOVARTIS VACCINES AND DIAGNOSTICS, INC. received a federal award currently valued at $14,768 from Office of the Assistant Secretary for Administration. VACCINE USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $10.1K — | A · 官方确认 INSMED INCORPORATED received a federal award currently valued at $10,105 from Department of Veterans Affairs. BELZUTIFAN (WELIREG) 40 MG USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $71.6K — | A · 官方确认 ORACLE CORPORATION received a federal award currently valued at $71,647 from National Oceanic and Atmospheric Administration. ORACLE SUPPORT USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $0 — | A · 官方确认 BIOMARIN PHARMACEUTICAL INC received a federal award currently valued at $0 from Department of Veterans Affairs. PALYNZIQ USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $26.8K — | A · 官方确认 INSMED INCORPORATED received a federal award currently valued at $26,775 from Department of Veterans Affairs. EMERGENCY AMIKACIN USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $378.7K — | A · 官方确认 BRISTOL-MYERS SQUIBB COMPANY received a federal award currently valued at $378,650 from Department of Veterans Affairs. ABECMA FOR CAR-T USAspending.gov | 2026-07-30 | 核验证据 |
Microsoft CorporationMSFT Defense Information Systems Agency ARMY CYBER COMMANDS MICROSOFT CONSULTING SERVICES AND MICROSOFT PREMIER SUPPORT | 政府合同 已完成 置信度 98% | $172.5M — | A · 官方确认 MICROSOFT CORPORATION received a federal award currently valued at $172,503,500 from Defense Information Systems Agency. ARMY CYBER COMMANDS MICROSOFT CONSULTING SERVICES AND MICROSOFT PREMIER SUPPORT USAspending.gov | 2026-07-30 | 核验证据 |
Adaptive Biotechnologies CorporationADPT Department of the Army CLONOSEQ FDA-CLEARED IN VITRO DIAGNOSTIC (IVD) TESTING SERVICES | 政府合同 进行中 置信度 98% | $245.7K — | A · 官方确认 ADAPTIVE BIOTECHNOLOGIES CORPORATION received a federal award currently valued at $245,700 from Department of the Army. CLONOSEQ FDA-CLEARED IN VITRO DIAGNOSTIC (IVD) TESTING SERVICES USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $31.2K — | A · 官方确认 INSMED INCORPORATED received a federal award currently valued at $31,229 from Department of Veterans Affairs. REZDIFFRA 80 MG USAspending.gov | 2026-07-30 | 核验证据 |
United Therapeutics CorporationUTHR Department of Veterans Affairs EMERGENCY TYVASO MEDICATION REFILLS | 政府合同 已完成 置信度 98% | $207.7K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $207,667 from Department of Veterans Affairs. EMERGENCY TYVASO MEDICATION REFILLS USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $298.6K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $298,648 from Department of Veterans Affairs. TYVASO USAspending.gov | 2026-07-30 | 核验证据 |
BioMarin Pharmaceutical Inc.BMRN Department of Veterans Affairs PHARMACY EMERGENCY FOR PALYNIQ FOR OKC | 政府合同 已完成 置信度 98% | $0 — | A · 官方确认 BIOMARIN PHARMACEUTICAL INC received a federal award currently valued at $0 from Department of Veterans Affairs. PHARMACY EMERGENCY FOR PALYNIQ FOR OKC USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $10.1K — | A · 官方确认 INSMED INCORPORATED received a federal award currently valued at $10,105 from Department of Veterans Affairs. ARIKAYCE (AMIKACIN) 590MG/8.4ML USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $10.1K — | A · 官方确认 INSMED INCORPORATED received a federal award currently valued at $10,105 from Department of Veterans Affairs. ARIKAYCE (AMIKACIN) 590MG/8.4ML USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $4.15B — | A · 官方确认 PFIZER INC received a federal award currently valued at $4,150,835,100 from Agency for International Development. COVID-19 VACCINES FOR INTERNATIONAL DONATION USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $44.2K — | A · 官方确认 IMMUNOCORE COMMERCIAL LLC received a federal award currently valued at $44,179 from Department of Veterans Affairs. KIMMTRAK USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $366.3K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $366,330 from Department of Veterans Affairs. TYVASO MEDICATION USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $11.11B — | A · 官方确认 PFIZER INC received a federal award currently valued at $11,110,134,066 from Department of the Army. COVID-19 VACCINE PRODUCTION USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $20.0K — | A · 官方确认 CVS HEALTH CORPORATION received a federal award currently valued at $19,980 from Environmental Protection Agency. COVID TESTING VOUCHERS WITH CVS USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $34.4K — | A · 官方确认 CATALYST PHARMACEUTICALS, INC received a federal award currently valued at $34,394 from Department of Veterans Affairs. AMIFAMPRIDINE (FIRDAPSE) 10MG USAspending.gov | 2026-07-30 | 核验证据 |
Catalyst PharmaceuticalsCPRX Department of Veterans Affairs AMIFAMPRIDINE (FIRDAPSE) 10MG TAB 120/PKG NDC: 69616-0211-06 | 政府合同 已完成 置信度 98% | $132.9K — | A · 官方确认 CATALYST PHARMACEUTICALS, INC received a federal award currently valued at $132,866 from Department of Veterans Affairs. AMIFAMPRIDINE (FIRDAPSE) 10MG TAB 120/PKG NDC: 69616-0211-06 USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $670.1K — | A · 官方确认 BRISTOL-MYERS SQUIBB COMPANY received a federal award currently valued at $670,085 from Department of Veterans Affairs. EMERGENCY BREYANZI INFUSION USAspending.gov | 2026-07-30 | 核验证据 |
Immunocore Holdings plcIMCR Department of Veterans Affairs KIMMTRAK (TEBENTAFUSP-TEBN) 100MCG/0.5ML VIAL,INJ NDC: 80446-0401-01 | 政府合同 已完成 置信度 98% | $86.7K — | A · 官方确认 IMMUNOCORE COMMERCIAL LLC received a federal award currently valued at $86,687 from Department of Veterans Affairs. KIMMTRAK (TEBENTAFUSP-TEBN) 100MCG/0.5ML VIAL,INJ NDC: 80446-0401-01 USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $52.1K — | A · 官方确认 ELI LILLY AND COMPANY received a federal award currently valued at $52,119 from Department of Veterans Affairs. F-18 AMYVID B+4 USAspending.gov | 2026-07-30 | 核验证据 |
Catalyst PharmaceuticalsCPRX Defense Threat Reduction Agency RESEARCH AND DEVELOPMENT SERVICES FOR IND FILING OF 3,4-DIAMINOPYRIDINE PHOSPHATE. | 政府合同 已完成 置信度 98% | $86.7K — | A · 官方确认 CATALYST PHARMACEUTICALS, INC received a federal award currently valued at $86,650 from Defense Threat Reduction Agency. RESEARCH AND DEVELOPMENT SERVICES FOR IND FILING OF 3,4-DIAMINOPYRIDINE PHOSPHATE. USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $148.0M — | A · 官方确认 MICROSOFT CORPORATION received a federal award currently valued at $147,963,533 from Defense Information Systems Agency. IGF::OT::IGF LABOR USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $10.1K — | A · 官方确认 INSMED INCORPORATED received a federal award currently valued at $10,105 from Department of Veterans Affairs. EMERGENCY PHARMACY ORDER. USAspending.gov | 2026-07-30 | 核验证据 |
Microsoft CorporationMSFT Defense Information Systems Agency MICROSOFT CONSULTING SERVICES (MCS) AND MICROSOFT PREMIER SUPPORT (MPS) FOR THE UNITED STATES MARINE CORPS (USMC. | 政府合同 已完成 置信度 98% | $220.5M — | A · 官方确认 MICROSOFT CORPORATION received a federal award currently valued at $220,450,481 from Defense Information Systems Agency. MICROSOFT CONSULTING SERVICES (MCS) AND MICROSOFT PREMIER SUPPORT (MPS) FOR THE UNITED STATES MARINE CORPS (USMC. USAspending.gov | 2026-07-30 | 核验证据 |
Immunocore Holdings plcIMCR Department of Veterans Affairs EMERGENCY PHARMACEUTICAL - SIX (6) KIMMTRAK / TEBENTAFUSP 100MCG | 政府合同 已完成 置信度 98% | $88.4K — | A · 官方确认 IMMUNOCORE COMMERCIAL LLC received a federal award currently valued at $88,358 from Department of Veterans Affairs. EMERGENCY PHARMACEUTICAL - SIX (6) KIMMTRAK / TEBENTAFUSP 100MCG USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $26.2K — | A · 官方确认 CVS HEALTH CORPORATION received a federal award currently valued at $26,200 from Department of Veterans Affairs. COMPENSATION GIFTCARDS FOR RESEARCH STUDIES USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $500 — | A · 官方确认 ASTRAZENECA PHARMACEUTICALS LP received a federal award currently valued at $500 from Defense Logistics Agency. 8509493425!OTHER MEDICAL USAspending.gov | 2026-07-30 | 核验证据 |
Oracle CorporationORCL National Oceanic and Atmospheric Administration MAINTENANCE AND VERSION UPGRADE SUPPORT FOR ORACLE | 政府合同 已完成 置信度 98% | $7.9K — | A · 官方确认 ORACLE USA, INC. received a federal award currently valued at $7,874 from National Oceanic and Atmospheric Administration. MAINTENANCE AND VERSION UPGRADE SUPPORT FOR ORACLE USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $68.4M — | A · 官方确认 PFIZER INC received a federal award currently valued at $68,359,693 from Office of Assistant Secretary for Preparedness and Response. IGF::OT::IGF USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 进行中 置信度 98% | $364.1K — | A · 官方确认 BRISTOL-MYERS SQUIBB COMPANY received a federal award currently valued at $364,139 from Department of Veterans Affairs. BREYANZI CAR T - TRANSPLANT USAspending.gov | 2026-07-30 | 核验证据 |
United Therapeutics CorporationUTHR Department of Veterans Affairs (QTY 18) TREPROSTINIL 0.6MG/ML SOLN,INHL,REFILL KIT - TYVASO 0.6MG/ML REFILL KIT NDC#: 66302-0206-02 | 政府合同 已完成 置信度 98% | $264.5K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $264,485 from Department of Veterans Affairs. (QTY 18) TREPROSTINIL 0.6MG/ML SOLN,INHL,REFILL KIT - TYVASO 0.6MG/ML REFILL KIT NDC#: 66302-0206-02 USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $0.04 — | A · 官方确认 NOVARTIS PHARMACEUTICALS CORPORATION received a federal award currently valued at $0 from Department of Veterans Affairs. ARZERRA MEDICATION USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $296.0K — | A · 官方确认 UNITED THERAPEUTICS CORP received a federal award currently valued at $296,031 from Department of Veterans Affairs. EO14042 TYVASCO USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $1.46B — | A · 官方确认 ELI LILLY AND COMPANY received a federal award currently valued at $1,463,250,000 from Department of the Army. LYCOV1404 BEBTELOVIMAB USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $477.4K — | A · 官方确认 NOVARTIS VACCINES AND DIAGNOSTICS, INC. received a federal award currently valued at $477,355 from Centers for Disease Control and Prevention. 2015-2016 ADULT FLU VACCINES USAspending.gov | 2026-07-30 | 核验证据 |
Amgen Inc.AMGN Office of Assistant Secretary for Preparedness and Response NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS) | 政府合同 进行中 置信度 98% | $7.3M — | A · 官方确认 AMGEN INC. received a federal award currently valued at $7,290,924 from Office of Assistant Secretary for Preparedness and Response. NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS) USAspending.gov | 2026-07-30 | 核验证据 |
政府合同 已完成 置信度 98% | $160.7M — | A · 官方确认 MICROSOFT CORPORATION received a federal award currently valued at $160,728,593 from Defense Information Systems Agency. IGF::OT::IGF - METSS FOR USMC USAspending.gov | 2026-07-30 | 核验证据 |
Apple Inc.AAPL Bureau of Indian Affairs and Bureau of Indian Education IPADS AND ACCESSORIES FOR PINE RIDGE SCHOOL | 政府合同 已完成 置信度 98% | $127.4K — | A · 官方确认 APPLE INC received a federal award currently valued at $127,387 from Bureau of Indian Affairs and Bureau of Indian Education. IPADS AND ACCESSORIES FOR PINE RIDGE SCHOOL USAspending.gov | 2026-07-30 | 核验证据 |
项目运营 已完成 置信度 92% | — 1 MW | B · 单方官方披露 Eli Lilly and Company reports Lilly Technical Center generator 2: 1 MW, Petroleum Liquids, retired. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator MBLG2: 1.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 已完成 置信度 92% | — 1 MW | B · 单方官方披露 Eli Lilly and Company reports Lilly Technical Center generator 5: 1 MW, All Other, retired. EIA-860M | 2026-06-01 | 核验证据 |
Regeneron Pharmaceuticals Inc.REGN Regeneron Pharmaceuticals Inc. · 777NG Natural Gas Internal Combustion Engine | 项目运营 已完成 置信度 92% | — 0.4 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 777NG: 0.4 MW, Natural Gas Internal Combustion Engine, retired. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 7.5 MW | B · 单方官方披露 Pfizer Inc reports Pfizer Groton Plant generator TG5: 7.5 MW, Natural Gas Steam Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.2 MW | B · 单方官方披露 Gilead Sciences Inc. Foster City reports Gilead Foster City Solar Project generator GFCS2: 0.2 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 10 MW | B · 单方官方披露 Pfizer Inc reports Pfizer Groton Plant generator TG 4: 10 MW, Natural Gas Steam Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 775G1: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 795G1: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Eli Lilly and Company reports Lilly Technical Center generator 3: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 10 MW | B · 单方官方披露 Pfizer Inc reports Pfizer Groton Plant generator GT-1: 10 MW, Natural Gas Fired Combustion Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
Bristol-Myers Squibb CompanyBMY Bristol Myers Squibb Lawrenceville · TG102 Natural Gas Fired Combustion Turbine | 项目运营 进行中 置信度 92% | — 5.6 MW | B · 单方官方披露 Bristol-Myers Squibb Co reports Bristol Myers Squibb Lawrenceville generator TG102: 5.6 MW, Natural Gas Fired Combustion Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 745G2: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 已完成 置信度 92% | — 2.5 MW | B · 单方官方披露 Pfizer Inc reports Pfizer Groton Plant generator TG 1: 2.5 MW, Natural Gas Steam Turbine, retired. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 777G1: 1 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 775G2: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 3 MW | B · 单方官方披露 United Therapeutics Corporation reports XPF Solar Field generator PV1: 3 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.1 MW | B · 单方官方披露 Gilead Sciences, Inc. - La Verne reports Gilead Sciences La Verne Rooftop Solar generator GSRBA: 1.1 MW, Batteries, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1 MW | B · 单方官方披露 Bristol-Myers Squibb Co reports Bristol Myers Squibb New Brunswick generator GEN2: 1 MW, Natural Gas Steam Turbine, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator MBLG1: 1.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 785G1: 1.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 10 MW | B · 单方官方披露 Pfizer Inc reports Pfizer Groton Plant generator TG 3: 10 MW, Natural Gas Steam Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.9 MW | B · 单方官方披露 Gilead Sciences Inc. Foster City reports Gilead Foster City Solar Project generator GFCS1: 0.9 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 745G1: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 765G1: 2.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 765G2: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Eli Lilly and Company reports Lilly Technical Center generator 4: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 735G2: 1 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 899G1: 2.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.7 MW | B · 单方官方披露 Gilead Sciences, Inc. - La Verne reports Gilead Sciences La Verne Rooftop Solar generator GSRSP: 1.7 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.1 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator B17PV: 0.1 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.7 MW | B · 单方官方披露 Gilead Sciences Inc. reports Gilead Oceanside Solar Project generator GOSSB: 0.7 MW, Batteries, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.5 MW | B · 单方官方披露 Gilead Sciences Inc. Foster City reports Gilead Foster City Solar Project generator GFCSB: 0.5 MW, Batteries, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 795G2: 2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
Regeneron Pharmaceuticals Inc.REGN Regeneron Pharmaceuticals Inc. · 778NG Natural Gas Internal Combustion Engine | 项目运营 已完成 置信度 92% | — 0.2 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 778NG: 0.2 MW, Natural Gas Internal Combustion Engine, retired. EIA-860M | 2026-06-01 | 核验证据 |
Regeneron Pharmaceuticals Inc.REGN Regeneron Pharmaceuticals Inc. · 771NG Natural Gas Internal Combustion Engine | 项目运营 进行中 置信度 92% | — 0.8 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 771NG: 0.8 MW, Natural Gas Internal Combustion Engine, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.8 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator P19PV: 0.8 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 已完成 置信度 92% | — 1 MW | B · 单方官方披露 Eli Lilly and Company reports Lilly Technical Center generator 1: 1 MW, Petroleum Liquids, retired. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1 MW | B · 单方官方披露 Eli Lilly and Company reports Lilly Technical Center generator K401: 1 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.2 MW | B · 单方官方披露 Bristol-Myers Squibb Co reports Bristol Myers Squibb Lawrenceville generator DG101: 1.2 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.5 MW | B · 单方官方披露 Gilead Sciences Inc. reports Gilead Oceanside Solar Project generator GOSSP: 1.5 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 1.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 735G1: 1.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 2.5 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator 777G2: 2.5 MW, Petroleum Liquids, (SB) Standby/Backup: available for service but not normally used. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 进行中 置信度 92% | — 0.4 MW | B · 单方官方披露 Regeneron Pharmaceuticals Inc. reports Regeneron Pharmaceuticals Inc. generator P9PV: 0.4 MW, Solar Photovoltaic, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
Bristol-Myers Squibb CompanyBMY Bristol Myers Squibb Lawrenceville · TG101 Natural Gas Fired Combustion Turbine | 项目运营 进行中 置信度 92% | — 4.3 MW | B · 单方官方披露 Bristol-Myers Squibb Co reports Bristol Myers Squibb Lawrenceville generator TG101: 4.3 MW, Natural Gas Fired Combustion Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
Bristol-Myers Squibb CompanyBMY Bristol Myers Squibb New Brunswick · GEN1 Natural Gas Fired Combustion Turbine | 项目运营 进行中 置信度 92% | — 9.5 MW | B · 单方官方披露 Bristol-Myers Squibb Co reports Bristol Myers Squibb New Brunswick generator GEN1: 9.5 MW, Natural Gas Fired Combustion Turbine, (OP) Operating. EIA-860M | 2026-06-01 | 核验证据 |
项目运营 已完成 置信度 92% | — 2.5 MW | B · 单方官方披露 Pfizer Inc reports Pfizer Groton Plant generator TG 2: 2.5 MW, Natural Gas Steam Turbine, retired. EIA-860M | 2026-06-01 | 核验证据 |